484 Results (Page 19 of 20)
Brazil Markets Research Reports
Brazil Ear Infection Therapeutics Market Analysis
Brazil Ear Infection Therapeutics Market valued at $295 Mn in 2022, is projected to reach $477 Mn by 2030 with a 6.2% CAGR. The increasing prevalence of ear infections, especially in children, is a major factor contributing to the expansion of the market for therapeutics aimed at treating ear infections. This surge serves as a driving force for substantial research, development efforts, and the introduction of various treatments to tackle this prevalent medical issue. Prominent players in this industry include Pfizer, Novartis, Roche, Johnson & Johnson, Bayer, Merck & Co., AstraZeneca, Sanofi, GlaxoSmithKline, and Takeda Pharmaceutical Company.
Brazil Compression Therapy Market Analysis
Brazil Compression Therapy Market was valued at $95 Mn in 2022 and is estimated to reach $158 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Sigvaris, Medi, Juzo, Jobst, Bauerfeind, Lympha Press, DJO Global, FLA Orthopedics, Al-Medical, and Eurofarma.
Brazil Bio-implant Market Analysis
The Brazil Bio-implant Market was valued at $1625 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $2592.4 Mn by 2030. The Brazil Bio-implant Market is growing due to Increasing Aging population, Technological Advancements, Rising Chronic Disease Prevalence. The market is primarily dominated by players such as Ossur, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Stryker Corporation, Zimmer Biomet, Medtronic, Boston Scientific Corporation, and Johnson & Johnson Services.
Brazil Mouth Ulcer Therapeutics Market Analysis
The Brazil Mouth Ulcer Therapeutics Market was valued at $38 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $53.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Eurofarma, EMS Pharma, ACHE and Sanofi among others.
Brazil Exosome Research Market Analysis
The Brazil Exosome Research Market was valued at $4.2 Mn in 2023 and is projected to grow at a CAGR of 17% from 2023 to 2023, to $12.7 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, Bio-Techne Crop, QIAGEN, Beckam Coulter, Lonza among others.
Brazil Bariatric Surgery Devices Market Analysis
The Brazil Bariatric Surgery Devices Market was valued at $66.5 Mn in 2023 and is projected to grow at a CAGR of 6.2% from 2023 to 2023, to $101.3 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Bhio Supply, Medicone, Scitech Medical, Medtronic, B. Braun, Johnson & Johnson, Cousin Surgery among others.
Brazil CT Scan Market Analysis
Brazil CT Scan Market was valued at $115.25 Mn in 2023 and is predicted to grow at a CAGR of 8.87% from 2023 to 2030, to $208.93 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing population and aging, and government initiatives. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Brazil Mental Health Apps Market Analysis
The Brazil Mental Health Apps Market was valued at $155 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $443.38 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and rising interest in preventive care. The industry is primarily dominated by players such as Headspace, Calm, Meditopia, and Meditation: Lojong among others.
Brazil Constipation Therapeutics Market Analysis
Brazil Constipation Therapeutics Market was valued at $455 Mn in 2022 and is estimated to reach $811 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The constipation therapeutics market is growing driven by the global rise in constipation prevalence associated with aging, sedentary lifestyles, and poor dietary habits, and further fuelled by an expanding elderly population more prone to chronic conditions. Key players in this industry include AbbVie, Allergan, Boehringer Ingelheim, EMS, Farmoquímica, Grünenthal, Johnson & Johnson, Norgine, Pfizer, and Sanofi.
Brazil Herbal Supplements Market Report
The Brazil Herbal Supplements Market was valued at $131.50 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $213.94 Mn by 2030. The key drivers of this industry include health awareness, government support, and growth in the wellness industry. The industry is primarily dominated by players such as Herbalife, Himalaya, NOW Foods, and Botanic Supplements among others.
Brazil Brain Cancer Therapeutics Market Analysis
Brazil Brain Cancer Therapeutics Market valued at $58 Mn in 2022, projected to reach $138 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Pfizer, AstraZeneca, Merck & Co., Siemens, Carestream Health, Eisai Co., Genentech, Bristol-Myers Squibb, Eli Lilly, and Sanofi.
Brazil Brugada Syndrome Market Analysis
The Brazil Brugada Syndrome Market was valued at $30 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $54.1 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the Brazil Brugada Syndrome Market are Eurofarma, EMS Pharma, Sanofi, Novo Nordisk, and Novartis, among others.
Brazil Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Brazil Clinical Nutrition for Chronic Kidney Diseases Market was valued at $39.20 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $63.10 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Brazil Adult Malignant Glioma Therapeutics Market Analysis
The Brazil Adult Glioma Therapeutics Market is valued at around $55 Mn in 2022 and is projected to reach $117 Mn by 2030, exhibiting a CAGR of 9.9% during the forecast period. The market's growth is being driven by the advent of innovative targeted therapies as well as increased awareness, both of which are addressing the growing prevalence of glioma, which is aided by improved diagnostic instruments and early detection procedures. Key players in the Brazil Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Novartis, Pfizer, AbbVie, Oncoclínica, Cmed, EMS, DASA. Etc.
Brazil Blood Disorder Therapeutics Market
Brazil Blood Disorder Therapeutics Market valued at $335 Mn in 2022, projected to reach $643 Mn by 2030 with a 8.5% CAGR. Rising prevalence of blood diseases, advanced therapies, and increased healthcare investment are driving the growth of the Brazil Blood Disorder Therapeutics Market. The Brazil market encompasses various players across different segments, including Pfizer, Sanofi, Novartis, Takeda Pharmaceuticals, CSL Behring, Alexion, Eurofarma, Hypera Pharma, Neo Quimica, Cristalia etc, among various others.
Brazil Dental Endodontics Market Analysis
Brazil Dental Endodontics Market was valued at $43.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $62.80 Mn by 2030. The key drivers of this industry include growing demand for cosmetic dentistry, Technological Advancements, rising prevalence of dental problems, and the ageing population. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others
Brazil Clinical Nutrition Market Analysis
The Brazil Clinical Nutrition Market was valued at $766.8 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $1179 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Oceandrop, Vitafor, Prodiet Medical Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.
Brazil Breast Pump Market Report
The Brazil Breast Pump Market was valued at $73.5 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $139.6 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Brazil Breast Pump Market are Ardo, CA-MI, Lansinoh, Microlife, Nubeca, and Nuby, among others.
Brazil Digital Biomarkers Market Analysis
Brazil Digital Biomarkers Market was valued at $72.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $314.11 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Brazil Congestive Heart Failure Therapeutics Market Analysis
The Brazil Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $258 Mn in 2022 to $436 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. An expanding patient base due to rising cardiac disease prevalence, increased healthcare access around the country, and a thriving R&D environment are the key factors driving the market growth in Brazil. The Brazil Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Hypera Pharma, Ache Laboratories, EMS Pharma, Neo Quimica, Teuto Brasileiro, etc, among various others.
Brazil Cancer Induced Bone Disease Therapeutics Market
Brazil Cancer Induced Bone Disease Therapeutics Market valued at $33 Mn in 2022, projected to reach $55 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising incidence of cancer, improved diagnostics and treatment, and the potential for local manufacturing. The industry is primarily dominated by players such as Advaxis, CancerVax, Pfizer, Takeda, Gradalis, Hikma, and Zentalis among others.
Brazil Medication Access Programs Market Analysis
The Brazil Medication Access Programs Market was valued at $137.2 Mn in 2023 and is predicted to grow at a CAGR of 15.6% from 2023 to 2030, to $378.6 Mn by 2030. The key drivers of this industry include the high prevalence of chronic disease, the large uninsured population, and government initiatives. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Brazil Dental Consumables Market Analysis
The Brazil Dental Consumables Market was valued at $845 Mn in 2023 and is projected to grow at a CAGR of 9.0% from 2023 to 2023, to $1544.7 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Institut Straumann AG, Coltene, EDLO ITM, ZimVie Inc, SIN Implant System among others.
Brazil Physiotherapy Equipment Market Analysis
The Brazil Physiotherapy Equipment Market was valued at $522.50 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $907.15 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Cremer, BTL Industries, EMS Emefarma, and Enraf-Nonius BV among others
Brazil Patient Adherence Programs Market Analysis
The Brazil Patient Adherence Programs Market was valued at $323.9 Mn in 2023 and is predicted to grow at a CAGR of 19.0% from 2023 to 2030, to $1094.6 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Brazil Patient Adherence Programs Market are Amil, Bradesco Saude, Novartis, Sanofi, and Pfizer, among others.